Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 1:20 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1657–1680 of 2,516 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Apoplexy Clear all

Conditions: Chronic Stroke
Interventions: Vagus Nerve Stimulation (VNS) Device, Sham VNS Device, Upper Extremity Rehabilitation; Device · Behavioral
Lead sponsor: NYU Langone Health; Other
Eligibility: 22 Years to 79 Years
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 2
States / cities: New York, New York • Richardson, Texas

Conditions: Stroke
Interventions: home-based sessions/family meetings with trained clinician; Procedure
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: 45 Years and older
Enrollment: 291 participants
Healthy volunteers: Healthy volunteers not accepted
U.S. locations: 6
States / cities: Boston, Massachusetts • Cambridge, Massachusetts

Conditions: Cardiac Output, Low, Stroke Volume
Interventions: Vitalstream; Device
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 58 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Stroke, Hemiparesis, Gait Dysfunction
Interventions: PAS at Rest, PAS - Active, PAS - Walking; Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Martinez, California

Conditions: Spasticity
Interventions: Phase 2; Low Dose MYOBLOC (15,000 Units), Phase 2; High Dose MYOBLOC (20,000 Units), Phase 2; Placebo, Phase 3; MYOBLOC, Phase 3; Placebo; Drug
Lead sponsor: Solstice Neurosciences, LLC, a subsidiary of MDD US Operations, LLC; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 4
States / cities: Downey, California • Boise, Idaho • Port Royal, South Carolina + 1 more

Conditions: Stroke, Motor Activity
Interventions: GAITRite assessment; Device
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 21 Years to 65 Years
Enrollment: 21 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Acute Stroke
Interventions: Acute Endovascular Stroke Treatment; Other
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years and older
Enrollment: 191 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 4
States / cities: New York, New York

Conditions: Atrial Fibrillation
Interventions: Dabigatran (Pradaxa), Vitamin K antagonist; Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years and older
Enrollment: 56,039 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016
U.S. locations: 1
States / cities: New York, New York

Conditions: Stroke, Motor Function
Interventions: Active Repetitive Transcranial Magnetic Stimulation (rTMS), Fluoxetine, Sham repetitive transcranial magnetic stimulation (rTMS), Placebo Fluoxetine; Device · Drug
Lead sponsor: Spaulding Rehabilitation Hospital; Other
Eligibility: 18 Years and older
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: Charlestown, Massachusetts

Conditions: Stroke, Ischemic, Stroke Hemorrhagic, Fever, Seizures, Metabolic Encephalopathy
Interventions: Transnasal Thermal Regulating Device; Device
Lead sponsor: CoolTech LLC; Industry
Eligibility: 18 Years to 95 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 3
States / cities: Washington D.C., District of Columbia • Baltimore, Maryland • Houston, Texas

Conditions: Acquired Brain Injury (Including Stroke)
Interventions: Facial Affect Recognition Training, Stories of Emotional Inference; Behavioral · Other
Lead sponsor: University at Buffalo; Other
Eligibility: 18 Years to 65 Years
Enrollment: 71 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2014
U.S. locations: 2
States / cities: Buffalo, New York • Charlotte, North Carolina

Conditions: Acute Ischemic Stroke Related to Tandem Occlusion, Acute Ischemic Stroke Due to Isolated Cervical Artery Occlusion
Interventions: Not listed
Lead sponsor: Azienda Unità Sanitaria Locale della Romagna; Other
Eligibility: Not listed
Enrollment: 4,230 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2026
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Stroke
Interventions: IpsiHand Therapy; Device
Lead sponsor: Neurolutions, Inc.; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 2
States / cities: Santa Cruz, California • St Louis, Missouri

Conditions: Intracerebral Hemorrhage, Acute Ischemic Stroke
Interventions: Supine cycle ergometry of the lower extremities; Device
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Stroke
Interventions: Hip Hop Stroke educational program, Nutrition Education program; Behavioral
Lead sponsor: Columbia University; Other
Eligibility: 7 Years and older
Enrollment: 4,614 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2016
U.S. locations: 1
States / cities: New York, New York

Conditions: Carotid Artery Stenosis, Carotid Artery Disease, Transient Ischemic Attack, Stroke
Interventions: Carotid endarterectomy, Neurological and neuropsychological evaluations; Procedure · Other
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older
Enrollment: 817 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2014
U.S. locations: 1
States / cities: New York, New York

Conditions: Stroke
Interventions: Barrier assessment / interactive educational intervention; Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: Not listed
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2010
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Stroke, Brain Ischemia
Interventions: ThermoSuit Cooling Induction, Magnesium Sulfate, tPA, Propofol, Etomidate, Neurothrombectomy; Device · Drug · Procedure
Lead sponsor: Life Recovery Systems; Other
Eligibility: 18 Years and older
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2023
U.S. locations: 4
States / cities: New Orleans, Louisiana • Danville, Pennsylvania • Wilkes-Barre, Pennsylvania + 1 more

Conditions: Ischemic Stroke
Interventions: NeuroThera® Laser System; Device
Lead sponsor: PhotoThera, Inc; Industry
Eligibility: 40 Years to 90 Years
Enrollment: 660 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 51
States / cities: Fort Smith, Arkansas • Berkeley, California • Encinitas, California + 45 more

Conditions: Diabetes Mellitus, Type 2
Interventions: Ticagrelor 60 mg, Ticagrelor placebo; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 50 Years to 130 Years
Enrollment: 19,271 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 295
States / cities: Alexander City, Alabama • Birmingham, Alabama • Fairhope, Alabama + 238 more

Conditions: Ischemic Stroke
Interventions: IV tpa (Alteplase) vs IA tpa (Alteplase); Drug
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 19 Years and older
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2008
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Stroke
Interventions: Recovery Rapids; Device
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 88 Years
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Stroke
Interventions: piclozotan low dose, placebo, piclozotan high dose; Drug
Lead sponsor: Daiichi Sankyo; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 43 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2007
U.S. locations: 25
States / cities: Los Angeles, California • San Francisco, California • Hartford, Connecticut + 22 more

Conditions: Stroke, Atrial Fibrillation
Interventions: Testing Devices, Cardea Solo by Cardiac Insight, Kardia Mobile by AliveCor; Device
Lead sponsor: University of Massachusetts, Worcester; Other
Eligibility: 50 Years to 100 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Worcester, Massachusetts

Search by objective public record fields.

Paired Vagus Nerve Stimulation Mechanisms

Families In Recovery From Stroke Trial (F.I.R.S.T.)

Perioperative Monitoring of Cardiac Surgery Patients With the Vitalstream Physiological Monitor

Plantarflexor PAS - Stroke

Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Lower Limb Spasticity

Gait Mate: Examining Neural Networks Engaged During Lower Extremity Movement in the MRI

New York City Mobile Interventional Stroke Team

Real-world Comparative Effectiveness of Dabigatran Versus Vitamin K Antagonist

Effects rTMS Combined With Fluoxetine on Motor Recovery in Stroke Patients

Transnasal Induction of Normothermia in Febrile Stroke Patients

Affect Recognition: Enhancing Performance of Persons With Acquired Brain Injury (ABI)

Risk Factors and Outcomes of Ischemic Stroke Associated With Tandem or Isolated Cervical Artery Occlusion in Anterior and Posterior Circulation

Ipsihand Device Use in Stroke Patients to Assess Functional Motor Outcomes

Biologic Mechanisms of Early Exercise After Intracerebral Hemorrhage

Effect of Intervention to Improve Stroke Recognition

Neuropsychometric Outcome After Carotid Endarterectomy

Increasing Stroke Treatment Through Interventional Change Tactics Study

Helping Stroke Patients With ThermoSuit Cooling

Effectiveness and Safety Trial of a New Ischemic Stroke Treatment Within 24 Hours From Stroke Onset (NEST-2)

A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes Mellitus

IV vs. IA tPA (Activase) in Acute Ischemic Stroke With CTA Evidence of Major Vessel Occlusion

Effect of Constraint-Induced Gaming Therapy in an Acute Care Setting

Efficacy of SUN N4057 in Subjects With Acute Ischemic Stroke and Measurable Penumbra on Magnetic Resonance Imaging (MRI)

Pulsewatch: Smartwatch Monitoring for Atrial Fibrillation After Stroke